Solid oral formulation of enzalutamide.

CL202600767A1Pending Publication Date: 2026-07-10BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CL202600767
Authority / Receiving Office: CL · CL
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-09-18
Filing Date: 2026-03-16
Publication Date: 2026-07-10

Application Information

Patent Timeline

18 Sep 2024

Priority

16 Mar 2026

Application

CL202600767

10 Jul 2026

Publication

CL202600767A1

IPC: A61K31/4166; A61K47/06; A61K47/10; A61K47/30; C07D233/86

CPC: C07D233/86; A61K31/4166; A61K9/2054; A61K9/146; A61K9/2095

Inventors: SHAH Dharmesh Mahendrabhai; BADIGER Aravind Manappa

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to novel oral solid pharmaceutical formulation of enzalutamide or pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipient. An enzalutamide pharmaceutical formulation comprising a one or more pharmaceutically acceptable polymers is provided by the present invention. In addition, the present invention also provides an improved process for preparation of enzalutamide oral solid pharmaceutical formulation.

Need to check novelty before this filing date? Find Prior Art